Stay updated on ICV Valproate Dose Ranging in Temporal Seizures Clinical Trial

Sign up to get notified when there's something new on the ICV Valproate Dose Ranging in Temporal Seizures Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ICV Valproate Dose Ranging in Temporal Seizures Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an escalation in the dose of valproate being delivered intracerebroventricularly to patients with medically refractory epilepsy in a pilot study.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:31.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has updated the 'Participation Criteria' section to provide detailed eligibility criteria for study participants, including age range, health conditions, and prior treatments. This change replaces the previous placeholder text with specific inclusion and exclusion criteria for the study.
    Difference
    50%
    Check dated 2024-05-22T21:34:26.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:17:49.000Z thumbnail image

Stay in the know with updates to ICV Valproate Dose Ranging in Temporal Seizures Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ICV Valproate Dose Ranging in Temporal Seizures Clinical Trial page.